Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage

This report describes the case of a 66-year-old man with non-small cell lung cancer and venous thromboembolism (VTE). Unfractionated heparin (UFH) was initially used to control VTE before chemotherapy. However, switching UFH to warfarin or edoxaban, a novel oral anticoagulant (NOAC), failed. Chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Tetsuaki, Mizugaki, Hidenori, Ikezawa, Yasuyuki, Furuta, Megumi, Takashima, Yuta, Kikuchi, Hajime, Goudarzi, Houman, Asahina, Hajime, Kikuchi, Junko, Kikuchi, Eiki, Sakakibara-Konishi, Jun, Shinagawa, Naofumi, Tsujino, Ichizo, Nishimura, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047974/
https://www.ncbi.nlm.nih.gov/pubmed/29434159
http://dx.doi.org/10.2169/internalmedicine.9741-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047974/
https://www.ncbi.nlm.nih.gov/pubmed/29434159
http://dx.doi.org/10.2169/internalmedicine.9741-17

Ejemplares similares